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Influence of Brain-Derived Neurotrophic
Factor Genetic Polymorphisms on the Ages
of Onset for Heroin Dependence in a Chinese Population
Chao Meng,1 Jie Lan,1 Youxin Wang,2 Manshu Song,2 Xuan Gao,1
Longjin Ran,1 Sim Moira,3 and Wei Wang1–3
Aim: The study aims at evaluating the association between brain-derived neurotrophic factor (BDNF) gene
polymorphisms and heroin-dependent patients in the Chinese population. Three polymorphisms of the BDNF-
gene (rs10835210, rs16917234, and rs6265) in 486 heroin-dependent patients and in 226 healthy controls were
genotyped for analyzing the association of these polymorphisms with age of onset of heroin dependence. We
defined the healthy cases as ‘‘unknown phenotype’’ and used the endophenotype (behavior traits) to stratify the
heroin dependents group on the basis of self-reporting traits for examining the association between BDNF
polymorphisms (rs10835210, rs16917234, and rs6265) and heroin dependence. Results: Allelic distributions of
BDNF gene polymorphisms did not differ significantly between heroin-dependent patients and controls.
However, we found that the AA carriers of BDNF rs6265 had an earlier onset of heroin dependence and a clearer
tendency of family history of heroin-dependent than GG carriers after controlling behavior characteristics across
rs6265 genotypes. Conclusions: Our findings suggested that the BDNF genetic polymorphism (rs6265) may have
effects on the age of onset of heroin dependence among the Chinese population. The BDNF gene could con-
tribute to vulnerabilities to heroin dependence.
Introduction
Heroin dependence is a problem of public health im-portance. The inducement of the disease is complicated.
Twin and family studies have showed that genetic factors
may interact with environmental factors, promoting heroin
dependence and relapse after withdrawal (Kreek et al., 2005;
Li and Burmeister, 2009).
Brain-derived neurotrophic factor (BDNF) belongs to the
neurotrophin superfamily (Matsuo et al., 2009), promotes
neuronal survival, and regulates the proliferation and differ-
entiation of nerve cells in the peripheral and central nervous
systems (Hartmann et al., 2001). BDNF serves an important
role during brain development and in synaptic plasticity
(Yang et al., 2009). Data derived from animal studies have
demonstrated that BDNF modulates dopaminergic and se-
rotonergic functions that are heavily linked to substance
abuse (Dluzen et al., 1999; Lyons et al., 1999). BDNF plays a
role in hippocampal function and episodic memory in hu-
mans, because a common single-nucleotide polymorphism
(SNP) (G196A or Val66Met. dbSNP: rs6265) resulting in a
valine (Val) to methionine (Met) substitution in the prodo-
main has shown to effect intracellular trafficking and activity-
dependent secretion of BDNF (Egan et al., 2003; Chen et al.,
2004).
Recently, many studies have been carried out on investi-
gating the genetic association of BDNF and drug dependence,
including heroin, alcoholism, smoking, and methamphet-
amine. Although there are some positive results (Beuten et al.,
2005; Cheng et al., 2005; Lang et al., 2007; Zhang et al., 2006;
Wojnar et al., 2009), opposite or null effects have also been
reported (Tsai et al., 2005; Matsushita et al., 2006; Itoh et al.,
2005).
The chromosomal markers whose alleles distinguish drug
dependents from controls were identified on the basis of
pooled-sample microarray, suggesting that a dinucleotide-
repeat polymorphism at the 5¢ end of the main coding exon of
BDNF was associated with vulnerability to poly-substance
abuse (Uhl et al., 2001). For heroin dependence, the first evi-
dencewas a study that compared the genotypes of 200 heroin-
dependent cases with 122 controls of Han Chinese men
(Cheng et al., 2005). Significant differences in the BDNF
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Val66Met genotype distribution were found between the
heroin-dependent subjects ( p = 0.045) and controls. Mean-
while, in the heroin-dependent group, the Val/Val homozy-
gote had a later onset of substance abuse compared with the
Met allele carriers, suggesting that the BDNF Val66Met
polymorphism or a nearby locus might be involved in the
pathogenesis of heroin dependence (Cheng et al., 2005). The
findings just mentioned suggest that BDNF may represent an
appropriate candidate gene that confers risk for substance
abuse and dependence.
The investigation of endophenotypes is an emerging
approach in genetic association studies (Hejjas et al., 2007), as it
holds promise for discovering the complex genetic background
of multifactorial phenotypes such as psychiatric disorders.
Gottesman and Shields (1973) described ‘‘endophenotypes’’ as
internal phenotypes discoverable by a ‘‘biochemical test or
microscopic examination’’. The theories and research patterns
of endophenotypes, including cue-elicited heroin craving, the
ages of onset for heroin dependence, certain behavior traits,
and so on, were introduced into the field of heroin research in
established studies (Franke et al., 2001; Li et al., 2006; Shao et al.,
2006). As one of the most complex diseases, phenotypes of
the heroin dependence can be analyzed using a self-reported
questionnaire, including the heroin-induced subjective re-
sponses and the process involved in dependence.
Therefore, we hypothesized that the BDNF gene poly-
morphisms would be associated with a certain process in
heroin dependence or some heroin-induced subjective re-
sponses. The healthy volunteers were defined as ‘‘unknown
phenotype’’ (the people who have no chance to get heroin),
and the endophenotype was used to stratify the case group in
this study. The investigation of association between BDNF
genes (rs6265, rs16917234, and rs10835210) and the en-
dophenotype could be helpful in understanding the mecha-
nism of genetic susceptibility of heroin dependence.
Materials and Methods
Recruitment and selection of participants
The heroin dependents in the Shanghai Voluntary Drug
Dependence Treatment Center in China were recruited.
Eligibility criteria included age 18 years or older; diagnosed as
‘‘opioid dependence’’ according to the Diagnostic and Statis-
tical Manual of Mental Disorders, Fourth Edition. Healthy
volunteers were recruited as healthy controls from a medical
examination center. All controls had neither past history, nor
a family history of drug dependence and psychiatric diseases.
The entire sampleswere ofHanChinese origin. The studywas
approved by both ethnic committees of the Shanghai Mental
Health Center and the Chinese Academy of Sciences.
Phenotype
The traits were measured by a self-reported questionnaire,
including a comfortable response on the first use of heroin,
age at onset, times of heroin dependence preceding the first
occurrence of pleasant feeling, the frequency and amount of
heroin used per day, the duration when a person transformed
the first use to dependence, and the occurrence of tolerance.
Moreover, we recorded whether a heroin-dependent had
been poisoned due to an overdose of heroin. The en-
dophenotypes were derived on the basis of self-reporting
behavioral traits. In addition, the healthy cases were defined
as an ‘‘unknown phenotype.’’
Genotype
The tSNPs were selected with the tagging algorithm with
criteria of r2 > 0.8 and a minor allele frequency ‡ 0.1 by the
Haploview program (version 4.2).
Genomic DNA was extracted from 200mL venous blood
with the QIAamp DNA Blood Mini Kit (Qiagen, Beijing,
China) according to the manual instructions. We genotyped
the DNA sequence variants of the BDNF gene using the
MassARRAY system (Sequenom, Inc., San Diego, CA). The
primer sequences are shown in Table 1. PCRswere performed
in a total volume of 5 mL containing 1mL DNA, 0.2 mL HotStar
Taq polymerase (5U/mL), 0.4 mL MgCl2 (25mM), 0.5 mL
polymerase chain reaction (PCR) buffer (10· ), 0.1 mL dNTPs
(2.5mM), 1.8 mL H2O, and 1mL of the designed primers. The
PCR conditions were as follows: 95C for 2min followed by
45 cycles of 95C for 20 s, 56C for 30 s and 72C for 1min,
and then an extension at 72C for 5min. The samples were
kept at 4C.
The products were treated with shrimp alkaline phospha-
tase to remove excess dNTPs after PCR. The PCR products
were used as templates for the primer extension reactions
using the iPlex1 Gold reagent kit (Sequenom, Inc.). The
products were spotted onto the MassARRAY Spectro CHIP
with an auto-spot arm and air dried. The target plate was then
inserted into the MALDI-TOF mass spectrometer of the
MassARRAY Compact System (Sequenom, Inc.). Genotypes
were automatically identified by the MassARRAY TYPER
software (version 3.4, Sequenom, Inc.).
Statistical analysis
Allelic frequencies between different phenotypes of the
case group and ‘‘unknown phenotype’’ of the health controls
were compared by the chi-square test or the Fisher’s exact
test where necessary. The onset age between different phe-
notypes was compared by the t-test or one-way analysis
of variance test. The Student–Newman–Kuls (SNK) test was
used formultiple comparisons. The significance for the results
was set at p< 0.05.
Results
Sample characteristics
A total of 486 heroin-dependents and 226 healthy volun-
teers (composed of control group) were enrolled in the study
(Table 2). The mean age of controls (37.47 – 17.85) was older
than that of cases (33.30 – 7.82). Men were 46.91% (228) and
46.46% (105) in cases and controls, respectively. In addiction,
the mean of onset age of drug dependence was 23.56– 7.89
years, and the average duration of dependence to heroin was
9.73 – 6.87 years.
Heroin-induced behaviors
The heroin-induced behaviors were interviewed face to
face, including reason for the first use of heroin, type of de-
pendence, subjective response to early opiate use, magnitude
of euphoria, feeling of rush, intention to abstain from
dependence, and other details (Table 3).
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Genotyping quality control
Genotypes for the three BDNF SNPs were carried out by
duplicates. A deviation from the Hardy–Weinberg equilib-
rium was not observed in any locus except for rs16917234
( p= 0.016986). The genotype data at this locus were re-
examined carefully, and the possibility of genotyping error
was excluded.
Association of BDNF SNPs and heroin dependence
No significant differences were found in the frequencies of
the genotype or allele in the three BDNF SNPs between the
heroin-dependent group and controls (rs10835210 genotype,
p = 0.9822, allele, p = 0.85956; rs16917234, genotype p= 0.0705,
allele, p= 0.42989; rs6265, genotype p= 0.4408, and allele
p = 0.19538) (Table 4).
The effect of BDNF genetic polymorphisms
on the age of onset of heroin dependence
The mean age of onset (in years) for the bearer groups were
22.32 – 6.22 for BDNF (rs6265) AA (n = 117), 24.19– 6.38 for
BDNF (rs6265) GG (n = 130), and 22.77– 6.19 for BDNF
(rs6265) AG (n = 230). The onset agewas significantly different
among the three genotypic groups ( p = 0.0423). The AA car-
riers had an earlier onset of heroin dependence than did GG
carriers by a further analysis with the SNK test (Table 5).
In addiction, the CC and CT carriers of BDNF (rs16917234)
had a later onset compared with the TT carriers, although
these values did not reach the power of statistical significance,
equaling to 25.09– 4.91, 22.65– 6.13 and 23.92– 6.66, respec-
tively. Meanwhile, the mean ages of onset for the C- and
T-allele bearer groups were 24.01– 6.53 and 23.00– 6.30,
respectively.
Association with heroin-induced behaviors
The associations between different heroin-induced behav-
iors and the allelic distributions of BDNF SNPs were not
statistically significant except for ‘‘peer’’ behavior. A signifi-
cant difference was found in the frequencies of the genotypes
in rs6265 between the ‘‘alone’’ group and the ‘‘with family’’
group ( p = 0.0489), and the carriers of GG had a less common
family history of drug dependence than the carriers of AA did
(Table 6).
Discussion
The results of our present study demonstrated that differ-
ent genotype carriers of BDNF had a different onset age
of heroin dependence. Although no significant differences
were found in the frequency of the genotype and allele be-
tween heroin dependents and controls (rs10835210 genotype:
p = 0.9822, allele, p = 0.85956; rs16917234 genotype: p= 0.0705,
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Table 2. Demographic Characteristics of
the Heroin Dependents and Controls in Han Chinese
Case
(n= 486)
Control
(n = 226)
Statistical
index p
Age (years) 33.30– 7.82 37.47– 17.85 t = 3.36 0.0009
Men (%) 228 (46.91) 105 (46.46) w2 = 0.0127 0.9101
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allele, p= 0.42989; rs6265. genotype: p = 0.4408. allele,
p = 0.19538), we observed that AA carriers of BDNF rs6265
had an earlier onset of heroin dependence and more family
history than GG carriers ( p= 0.0423 and p= 0.0489 respec-
tively). In addition, TT carriers of BDNF rs16917234 had an
earlier onset of heroin dependence compared with CC carriers,
although the values did not reach statistical significance
( p= 0.0798). Our study showed that the BDNF genetic poly-
morphism may have effects on the age of onset of heroin de-
pendence among the Chinese population. Our findings are
consistent with Cheng’s study (Cheng et al., 2005), suggesting
that the BDNF genetic polymorphism may affect the age of
onset of substance dependence, and theMet allelemay be a risk
factor for early-onset substance dependence. However, there
was controversy among reports. Regarding the early onset of
heroin dependence, no significant difference was observed
betweenGA carriers andGGorAAcarriers at the BDNF rs6265
locus (Hou et al., 2010); whereas Jia et al. (2011) reported that the
onset of dependence was significantly earlier in individuals
with GG or GA genotypes compared with AA individuals
Table 3. Behavior and Clinical Characteristics of 486 Heroin-Dependent Subjects
1 2 3 4
Missing
values
Type of dependence 66 362 29 29 1: smoking
(14.44) (79.21) (6.34) 2: injection
3: both
Reason for first use of heroin 30 337 23 87 9 1: physical
(6.29) (70.65) (4.82) (18.24) 2: psychologic
3: environment
4: combined
Subjective response to early opiate use 340 73 73 0 1: uncomfortable
(69.96) (15.02) (15.02) 2: euphoria
3: unclear
Magnitude of euphoria 89 118 279 0 1: intense
(18.31) (24.28) (57.41) 2: moderate
3: mild
Feeling of rush 330 156 0 1: yes
(67.90) (32.10) 2: no
Peer 328 137 20 1 1: alone
(67.63) (28.25) (4.12) 2: friends
3: family
Intention to abstain from dependence 148 327 8 3 1: yes
(30.64) (67.7) (1.66) 2: unclear
3: no
Toxic from overdose 187 299 0 1: yes
(38.48) (61.52) 2: none
Table 4. Allelic and Genotype Frequencies for Heroin-Dependent Patients
and Controls for Single-Nucleotide Polymorphisms rs10835210, rs16917234, and rs6265
No. (%)
Control Case Chi-square p value
rs10835210 Genotype AA 18 (7.96) 38 (7.82) 0.0359 0.9822
CC 115 (50.88) 251 (51.65)
CA 93 (41.15) 197 (40.53)
Allele A 129 (28.54) 273 (28.09) 0.0300 0.85956
C 323 (71.46) 699 (71.91)
rs16917234 Genotype CC 13 (5.75) 12 (2.47) 5.3032 0.0705
TT 156 (69.03) 336 (69.14)
CT 57 (25.22) 138 (28.40)
Allele C 83 (18.36) 162 (16.67) 0.6200 0.42989
T 369 (81.64) 810 (83.33)
rs6265 Genotype AA 46 (20.35) 117 (24.07) 1.6385 0.4408
GG 71 (31.42) 135 (27.78)
AG 109 (48.23) 234 (48.15)
Allele A 201 (44.47) 468 (48.15) 1.6800 0.19538
G 251 (55.53) 504 (51.85)
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among heroin-dependent individuals. These differences in the
reported studies might be influenced by sample size and ge-
netic heterogeneity. The subjects in Hou’s study were 96 her-
oin-dependent individuals, and such a small sample size of the
study may limit the generalizability of the results. The study
outcome might be as a result of the stratification effect in the
sample collection as well. In Jia’s report, the large sample size
(case number 487; control number 492) provided sufficient data
that clarify the relevance of the polymorphisms in the popu-
lations from the northwest part of China. The cases and con-
trols in our study were chosen from Shanghai, residents in the
south-eastern part of China. In addition, the disparity in find-
ings betweenour study and the other investigationsmay reflect
the differences in the other considerable factors associatedwith
the onset age of heroin dependence, such as socioeconomic
status, perceived peer use, and accessibility of substances. The
existence of other susceptibility genes to heron dependence
could not be excluded either.
The investigation of the genetic basis for the onset of drug
dependence is very important on account of the early age at
the first use, which is a marker of elevated risk for developing
drug use disorders (Sartor et al., 2009). There were conflicting
heterogeneities among studies that probed the relationship
between the BDNF polymorphism and heroin dependence. If
the polymorphism does not have a direct effect, but is rather
in linkage disequilibrium with the true associated allele to
varying degrees in different populations, inconsistent associ-
ations with the polymorphism could be the result due to
population differences in linkage disequilibrium patterns
(Petryshen et al., 2010).
BDNF has important roles in neural development, cell
survival, and synaptic plasticity. The lower-activity allele
(Met66) was associated with reduced cognitive performance
(Cheng et al., 2005). However, the higher-activity BDNF al-
lele (Val66) was associated with BPD (Neves-Pereira et al.,
2002) and substance abuse (Cheng et al., 2005; Sim et al.,
2010). Chronic drug exposure increased BDNF levels in the
ventral tegmental area neurons (Vargas-Perez et al., 2009).
The 66Met allele of the Val66Met polymorphism of the
BDNF gene was associated with lower BDNF secretion in
response to neuronal stimulation compared with the 66Val
allele in human beings (Tsai, 2007). Thus, subjects carrying the
Val allele may have higher intracranial BDNF activity than
people who are Met/Met homozygous (Egan et al., 2003).
Therefore, 66Val carriers have an increased euphoric effect after
drug abuse, which makes them more vulnerable to have drug
abuse. Previous studies found that theMet allelemight be a risk
allele in the development of obsessive–compulsive disorder
(OCD) and was associated with an earlier age at onset of OCD
in men (Hemmings et al., 2008; Rocha et al., 2010). These find-
ings suggested that the BDNF Val66Met polymorphism may
have genetic pleiotropy, which is the ability of a mutation in a
single gene to give rise to multiple phenotypic outcomes, and,
thus, simultaneously convey separate advantageous traits and
disadvantageous traits in the sameorganism (Hong et al., 2011).
One research indicated the lack of a significant frequency dif-
ference of the SNPs between heroin dependents and control
subjects in Japan (Itoh et al., 2005), whereas the results were
opposite in the study of a Taiwan population (Cheng et al.,
2005). In addition, there was a trend toward higher BDNF
66Val homozygote frequency in both European- and African-
American polysubstance abusers than in controls, although
these values did not reach statistical significance (Liu et al.,
2005). The inconsistent findings apparentlymay be attributable
to the lack of proper control over multi-factors influencing
heroin dependence in real-world settings.
Table 5. Different Genotypes and Alleles
on Onset Age of Heroin Dependence
N Mean
Standard
deviation F/t p value
rs10835210 Genotype AA 38 23.87 6.06 0.35 0.7021
CC 246 23.00 6.48
CA 193 22.95 6.08
Allele A 231 23.10 6.07 0.24 0.8124
C 439 22.98 6.30
rs16917234 Genotype CC 11 25.09 4.91 2.54 0.0798
TT 335 22.65 6.13
CT 131 23.92 6.66
Allele C 142 24.01 6.53 1.65 0.0996
T 466 23.00 6.30
rs6265 Genotype AA 117 22.32a 6.22 3.18 0.0423
GG 130 24.19a 6.38
AG 230 22.77 6.19
Allele A 347 22.62 6.19 1.41 0.1580
G 360 23.29 6.29
aFurther analysis with SNK test revealed that onset age of AA
carriers was earlier than that of GG carriers.
SNK, Student–Newman–Keuls.
Table 6. Genotype Frequencies for the Brain-Derived Neurotrophic
Factor Genetic Polymorphism in Different Peers
No. (frequency %)
SNPs Genotype/allele Alone With family Control Chi-square p value
rs10835210 AA 28 (8.54) 1 (5.00) 18 (7.96) 1.5986 0.8090
CC 169 (51.52) 13 (65.00) 115 (50.88)
CA 131 (39.94) 6 (30.00) 93 (41.15)
rs16917234 CC 10 (3.05) 0 (0) 13 (5.75) 4.4758 0.3454
TT 225 (68.6) 16 (80.00) 156 (69.03)
CT 93 (28.35) 4 (20.00) 57 (25.22)
rs6265 AA 81 (24.70) 8 (40.00) 46 (20.35) 6.0349 0.0489
GG 96 (29.27) 1 (5.00) 71 (31.42)
AG 151 (46.04) 11 (55.00) 109 (48.23)
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The definition of phenotypes is a major problem for any
genetic study of dependence. For most genetic association
studies, a control group is drawn from the majority of a pop-
ulation that has not been exposed to the drug. The power to
detect the genetic effect on drug dependence is lowered by the
use of unscreened controls. A suitable control group for a ge-
netic associate study would not be the general population, but
rather individualswith the same environmental background in
order to control for this major effect thatmay otherwise swamp
the genetic effect (Buckland, 2008). Given this background, it is
even less easy to find the samples who have been sufficiently
exposed to heroin but are clearly not addicted.
As for the ‘‘peer’’ behavior, we also observed that the fre-
quencies of the genotype in rs6265 between the ‘‘alone’’ group
and ‘‘with family’’ group ( p= 0.0489) were significantly dif-
ferent. Our results suggested that the carriers of AA of BDNF
rs6265 had a more common family history of drug depen-
dence than the carriers of GG did.
In the present study, we, therefore, defined the healthy cases
as ‘‘unknown phenotype’’; and used ‘‘endophenotype’’ to
stratify the heroin dependents group; and aimed at looking for
the exact association between the BDNF gene (rs10835210,
rs16917234, and rs6265) and heroin dependents for discovering
the complex genetic background ofmulti-factorial phenotypes.
We used the endophenotype, classified by the self-reported
behaviors or objective responses on heroin dependence, to split
heroin dependents into two groups. For instance, those who
mainly reported rush responses on the use of heroin
were classified as being endophenotype positive; while others
who reported no rush responses were classified as being en-
dophenotype negative. Most associations between different
heroin-induced behaviors with the genotype and allele distri-
bution of BDNF SNPs were not significant statistically except
for ‘‘peer’’ and onset age of heroin dependence.
There are limitations in this study. Heroin-induced be-
havioral traits were measured by a self-reported question-
naire. The recall bias might have been inevitably involved
when the information was collected based on the recall of
subjective reactions that occurred in a distant past. Other
suitable types of endophenotypes for heroin dependence still
need to be found, such as P300 event-related potential (Iacono
et al., 2000), personal traits (Ebstein et al., 1996), and with-
drawal symptoms (Sander et al., 2006). The imbalance of
sample size would impact the results of between-group
analysis. However, it does not impact the association between
the SNP site and phenotype.
In conclusion, the BDNF gene could contribute to vulner-
abilities to heroin dependence. AA carriers (BDNF rs6265)
had an earlier onset of heroin dependence than did GG car-
riers ( p = 0.0423). The CC carriers of BDNF rs16917234 had a
later onset of heroin dependence compared with the TT car-
riers, although these values did not reach statistical signifi-
cance ( p= 0.0798). Our findings suggested that BDNF genetic
polymorphisms (rs6265 and rs16917234) may have effects on
the age of onset of heroin dependence among the ChineseHan
population. To our knowledge, this is the first attempt in
mainland China that simultaneously examines the impact of
BDNF genetic polymorphisms rs6265 and rs16917234 on the
onset age of heroin dependence. In addition, we did not find
any association between SNP rs10835210 and heroin depen-
dence, and, therefore, this polymorphism unlikely plays a
major role in the pathogenesis of heroin dependence in our
Chinese Han sample. A further study conducted on inde-
pendent samples is needed to confirm these findings.
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